Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01084239 · ClinicalTrials.gov registry record · Phase 3
Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography
A Phase 3 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,000
- Enrollment target
NCT01084239: Completed Phase 3 study, sponsored by Massachusetts General Hospital.
NCT01084239 is a Phase 3 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01084239, a Phase 3 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The growing availability of cardiac computed tomography (CT)\* in emergency departments (EDs) across the U.S. expands the opportunities for its clinical application, but also heightens the need to define its appropriate use in the evaluation of patients with acute chest pain. To address this need, we performed a randomized diagnostic trial (RDT) to determine whether integrating cardiac CT, along with the information it provides on coronary artery disease (CAD) and left ventricular (LV) function, can improve the efficiency of the management of these patients (i.e. shorten length of hospital stay, increase direct discharge rates from the ED, decreasing healthcare costs and improving cost effectiveness while being safe).
Interventions
- RADIATION Cardiac Computed Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01084239
The ClinicalTrials.gov registry entry for NCT01084239 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Computed Tomography is the first listed.
NCT01084239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01084239 about?
NCT01084239 is a clinical study titled "Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography". The growing availability of cardiac computed tomography (CT)\* in emergency departments (EDs) across the U.S. expands the opportunities for its clinical application, but also heightens the need to define its appropriate use in the evaluation of patients with acute chest pain. To address this need, w...
What is the current status of trial NCT01084239?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,000 participants. The study started on 2010-04. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01084239?
The interventions under investigation include: Cardiac Computed Tomography (RADIATION).
Who is sponsoring clinical trial NCT01084239?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.